Balchem Corporation
NASDAQ:BCPCChemicals - Specialty
+$1.03 today
- Market cap
- $5.36B
- Beta
- 0.83
- P/E (TTM)
- 33.8
- EPS (TTM)
- $4.90
- Dividend yield
- 0.58%
Volume 0.21M
Average 0.21M
BCPC Operating Cash Flow
Cash generated by the company's core business operations during the period.
Balchem CorporationNASDAQ: BCPC
Operating Cash Flow · Q3 FY2026 · quarter ended Sep 2026
Operating cash flow grows, but more slowly than its trailing trend
Q3 FY2026 operating cash flow of $69.77M rose 6.4% year over year, behind the +11.0% change in trailing-twelve-month operating cash flow. Sequentially, it rose 49.4% from the prior quarter. Over 3 fiscal years it compounded at +16.1% a year.
Context
- Operating cash flow amounted to 20.9% of revenue in FY2025, up 1.8 pp from a year earlier.
- Operating cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +6.4% toward the trailing-twelve-month pace of +11.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 216.56M USD
- Year-over-year change
- +19.0%
- 4-year CAGR
- +7.8%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 216.56M | +19.0% |
| FY2024 | 2024-12-31 | 182M | -1.0% |
| FY2023 | 2023-12-31 | 183.76M | +32.6% |
| FY2022 | 2022-12-31 | 138.54M | -13.7% |
| FY2021 | 2021-12-31 | 160.51M | — |
Operating Cash Flow vs competitors
How BCPC compares with its peers on the latest reported figures
- BCPC's LTM Sep 2026 operating cash flow of $223.82M is the 6th largest of the 11 companies compared; the peer median is $250.43M.
- Its year-over-year change of +11.0% is the 5th highest of 11, against a peer median of +2.1%.
- Operating cash flow amounts to 20.2% of revenue for BCPC, versus a peer median of 9.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.16B | +5.4% | +28.9% | 11.6% | |
| LTM Jun 2026 | $991M | -1.1% | -0.2% | 11.2% | |
| LTM Jun 2026 | $805M | -31.6% | +83.8% | 11.2% | |
| LTM Jun 2026 | $394M | +144.7% | — | 21.4% | |
| LTM Aug 2026 | $289.37M | +19.4% | +0.9% | 8.1% | |
| LTM Sep 2026 | $223.82M | +11.0% | +16.1% | 20.2% | |
| LTM Sep 2026 | $211.5M | -17.5% | -8.9% | 6.2% | |
| LTM Mar 2026 | $157.87M | +23.9% | -2.7% | 6.7% | |
| LTM Sep 2026 | $148.78M | +21.1% | +23.1% | 13.1% | |
| LTM Jun 2026 | $125.5M | -8.3% | +19.2% | 6.8% | |
| LTM Jun 2026 | $123.37M | -10.3% | +119.6% | 7.2% | |
| Peer median (excluding BCPC) | $250.43M | +2.1% | +19.2% | 9.6% | |
Competitors are the stored peer set for BCPC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 96.1M | 105.37M | 108.54M | 128.48M | 154.85M |
| Depreciation & Amortization | 48.88M | 51.85M | 54.94M | 47.97M | 45.69M |
| Deferred Income Tax | (5.94M) | (8.36M) | (10.81M) | (6.78M) | 6.26M |
| Stock-Based Compensation | 10.8M | 13.22M | 16.05M | 16.68M | 18.06M |
| Change in Working Capital | 10.93M | (25.22M) | 20.01M | (6.12M) | (7.46M) |
| Accounts Receivables | (20.7M) | (3.62M) | 6.97M | 5.58M | (20.85M) |
| Inventory | (21.02M) | (7.8M) | 10.53M | (22.79M) | 3.64M |
| Accounts Payables | 46.19M | (15.54M) | 3.55M | 9.07M | 11.29M |
| Other Working Capital | 6.47M | 1.74M | (1.04M) | 2.03M | (1.54M) |
| Other Non-Cash Items | (257K) | 1.68M | (4.97M) | 1.77M | (835K) |
| Operating Cash Flow | 160.51M | 138.54M | 183.76M | 182M | 216.56M |
| Capital Expenditures | (37.45M) | (50.29M) | (37.89M) | (35.66M) | (43.49M) |
| Acquisitions (Net) | 318K | (365.78M) | (1.54M) | (24.16M) | (49K) |
| Purchases of Investments | 0 | 0 | 0 | 0 | (353K) |
| Sales of Investments | 0 | 0 | 2.74M | 0 | 0 |
| Other Investing Activities | 1.83M | 56K | 1.88M | 89K | 0 |
| Investing Cash Flow | (35.3M) | (416.01M) | (34.81M) | (59.74M) | (43.89M) |
| Debt Repayment | (55.16M) | 300.84M | (131.22M) | (119.79M) | (26.19M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 9.31M |
| Common Stock Repurchased | (35.24M) | (35.42M) | (4.47M) | (5.68M) | (107.64M) |
| Dividends Paid | (18.72M) | (20.71M) | (22.87M) | (25.58M) | (28.29M) |
| Other Financing Activities | 6.94M | 1.98M | 5.24M | 17.23M | 0 |
| Financing Cash Flow | (102.18M) | 246.68M | (153.32M) | (133.82M) | (152.81M) |
| Effect of Forex Changes | (4.37M) | (5.88M) | 2.26M | (3.38M) | 5.2M |
| Net Change in Cash | 18.67M | (36.68M) | (2.11M) | (14.93M) | 25.06M |
| Free Cash Flow | 123.07M | 88.25M | 145.87M | 146.34M | 173.07M |
Balchem Corporation
NASDAQ:BCPC
Intrinsic Alpha fair value
Locked
Current Price
$168.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.